Dr Reddys Laboratories (RDY) Change in Acquisitions & Divestments (2009 - 2026)

Dr Reddys Laboratories has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $166.3 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 503.06% year-over-year to $166.3 million in Q2 2026; TTM through Jun 2026 was $2.6 billion, a 128.83% increase from a year earlier, with the FY2026 full-year figure at $209.0 million, down 93.61% from the prior year.
• Change in Acquisitions & Divestments was $166.3 million for Q2 2026 at Dr Reddys Laboratories, down from $1.0 billion in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $1.4 billion in Q3 2024, with the low at -$831.8 million in Q1 2024.
• Average Change in Acquisitions & Divestments over 5 years is $379.4 million, with a median of $399.4 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments plunged 288.93% in 2024, then soared 503.06% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $209.7 million in 2022, then soared by 32.87% to $278.7 million in 2023, then surged by 395.81% to $1.4 billion in 2024, then retreated by 24.55% to $1.0 billion in 2025, then tumbled by 84.05% to $166.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $166.3 million (Q2 2026), $1.0 billion (Q3 2025), and $27.6 million (Q2 2025), per Business Quant data.